Action	Date	Notes	Link
article xml file uploaded	17 November 2021 13:20 CET	Original file	-
article xml uploaded.	17 November 2021 13:20 CET	Update	https://www.mdpi.com/2072-6694/13/22/5758/xml
article pdf uploaded.	17 November 2021 13:20 CET	Version of Record	https://www.mdpi.com/2072-6694/13/22/5758/pdf
article supplementary file uploaded.	17 November 2021 13:20 CET	-	https://www.mdpi.com/2072-6694/13/22/5758#supplementary
article html file updated	17 November 2021 13:21 CET	Original file	-
article html file updated	30 July 2022 17:09 CEST	Update	-
article html file updated	7 September 2025 05:22 CEST	Update	https://www.mdpi.com/2072-6694/13/22/5758/html

Cite

Export citation file: BibTeX | EndNote | RIS

MDPI and ACS Style

Aughton, K.; Elander, N.O.; Evans, A.; Jackson, R.; Campbell, F.; Costello, E.; Halloran, C.M.; Mackey, J.R.; Scarfe, A.G.; Valle, J.W.; et al. hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. Cancers 2021, 13, 5758. https://doi.org/10.3390/cancers13225758

AMA Style

Aughton K, Elander NO, Evans A, Jackson R, Campbell F, Costello E, Halloran CM, Mackey JR, Scarfe AG, Valle JW, et al. hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. Cancers. 2021; 13(22):5758. https://doi.org/10.3390/cancers13225758

Chicago/Turabian Style

Aughton, Karen, Nils O. Elander, Anthony Evans, Richard Jackson, Fiona Campbell, Eithne Costello, Christopher M. Halloran, John R. Mackey, Andrew G. Scarfe, Juan W. Valle, and et al. 2021. "hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA" Cancers 13, no. 22: 5758. https://doi.org/10.3390/cancers13225758

APA Style

Aughton, K., Elander, N. O., Evans, A., Jackson, R., Campbell, F., Costello, E., Halloran, C. M., Mackey, J. R., Scarfe, A. G., Valle, J. W., Carter, R., Cunningham, D., Tebbutt, N. C., Goldstein, D., Shannon, J., Glimelius, B., Hackert, T., Charnley, R. M., Anthoney, A., ... Greenhalf, W. (2021). hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA. Cancers, 13(22), 5758. https://doi.org/10.3390/cancers13225758

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI